EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low‐dose aspirin, maternal cardiometabolic health, and offspring respiratory health 9 to 14 years after delivery: Findings from the EAGeR Follow‐up Study

May Shaaban, Zachary D Shepelak, Joseph B Stanford iD, Robert M Silver iD, Sunni L Mumford iD, Enrique F Schisterman, Stefanie N Hinkle iD, Flory L Nkoy, Lauren Theilen iD, Jessica Page, Jessica G Woo, Benjamin H Brown und 2 weitere

Paediatric and Perinatal Epidemiology · 2024

DOI: 10.1111/ppe.13097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Paediatric and Perinatal Epidemiology, 2024. Verfasst von May Shaaban und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family and Preventive Medicine, University of Utah Health, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Aspirin, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accumulating evidence shows that peri‐conceptional and in‐utero exposures have lifetime health impacts for mothers and their offspring.

Objectives

We conducted a Follow‐Up Study of the Effects of Aspirin in Gestation and Reproduction (EAGeR) trial with two objectives. First, we determined if women who enrolled at the Utah site ( N = 1001) of the EAGeR trial (2007–2011, N = 1228) could successfully be contacted and agree to complete an online questionnaire on their reproductive, cardio‐metabolic, and offspring respiratory health 9–14 years after original enrollment. Second, we evaluated if maternal exposure to low‐dose aspirin (LDA) during pregnancy was associated with maternal cardio‐metabolic health and offspring respiratory health.

Methods

The original EAGeR study population included women, 18–40 years of age, who had 1–2 prior pregnancy losses, and who were trying to become pregnant. At follow‐up (2020–2021), participants from the Utah cohort completed a 13‐item online questionnaire on reproductive and cardio‐metabolic health, and those who had a live birth during EAGeR additionally completed a 7‐item questionnaire on the index child's respiratory health. Primary maternal outcomes included hypertension and hypercholesterolemia; primary offspring outcomes included wheezing and asthma.

Results

Sixty‐eight percent ( n = 678) of participants enrolled in the follow‐up study, with 10% and 15% reporting maternal hypertension and hypercholesterolemia, respectively; and 18% and 10% reporting offspring wheezing and asthma. We found no association between maternal LDA exposure and hypertension (risk difference [RD] −0.001, 95% confidence interval [CI] −0.05, 0.04) or hypercholesterolemia (RD −0.01, 95% CI −0.06, 0.05) at 9–14 years follow‐up. Maternal LDA exposure was not associated with offspring wheezing (RD −0.002, 95% CI −0.08, 0.08) or asthma (RD 0.13, 95% CI 0.11, 0.37) at follow‐up. Findings remained robust after considering potential confounding and selection bias.

Conclusions

We observed no association between LDA exposure during pregnancy and maternal cardiometabolic or offspring respiratory health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinPrenatal Exposure Delayed EffectsHumansFemalePregnancyFollow-Up StudiesAdultChildAdolescentUtahYoung AdultMaternal HealthMaleChild HealthAsthma

Stichwörter der Autor:innen

follow‐up recruitmentlow‐dose aspirinpost‐conceptionpregnancyresearch subject recruitment

Substanzen

Aspirin

Autor:innen und Institutionen

  • Department of Family and Preventive Medicine, University of Utah Health, Salt Lake City, Utah, USA.
  • Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah, USA.
  • Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, University of Utah Health, Salt Lake City, Utah, USA.
  • Department of Obstetrics and Gynecology, Intermountain Healthcare, Salt Lake City, Utah, USA.

ORCID-Profile: Joseph B Stanford, Robert M Silver, Sunni L Mumford, Stefanie N Hinkle, Lauren Theilen, Karen C Schliep

Förderung

  • NIA NIH HHS
  • NHLBI NIH HHS
  • National Institute on Aging
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Shaaban, M., Shepelak, Z. D., Stanford, J. B., Silver, R. M., Mumford, S. L., Schisterman, E. F., Hinkle, S. N., Nkoy, F. L., Theilen, L., Page, J., Woo, J. G., Brown, B. H., Varner, M. W., & Schliep, K. C. (2024). Low‐dose aspirin, maternal cardiometabolic health, and offspring respiratory health 9 to 14 years after delivery: Findings from the EAGeR Follow‐up Study. Paediatric and Perinatal Epidemiology. https://doi.org/10.1111/ppe.13097

Vancouver

Shaaban M, Shepelak ZD, Stanford JB, Silver RM, Mumford SL, Schisterman EF, et al. Low‐dose aspirin, maternal cardiometabolic health, and offspring respiratory health 9 to 14 years after delivery: Findings from the EAGeR Follow‐up Study. Paediatric and Perinatal Epidemiology. 2024. doi:10.1111/ppe.13097

BibTeX
@article{Shaaban2024,
  author = {Shaaban, May and Shepelak, Zachary D and Stanford, Joseph B and Silver, Robert M and Mumford, Sunni L and Schisterman, Enrique F and Hinkle, Stefanie N and Nkoy, Flory L and Theilen, Lauren and Page, Jessica and Woo, Jessica G and Brown, Benjamin H and Varner, Michael W and Schliep, Karen C},
  title = {Low‐dose aspirin, maternal cardiometabolic health, and offspring respiratory health 9 to 14 years after delivery: Findings from the EAGeR Follow‐up Study},
  journal = {Paediatric and Perinatal Epidemiology},
  year = {2024},
  doi = {10.1111/ppe.13097}
}
Kostenlos starten →